Safety and efficacy of sugammadex in management of patients with myasthenia gravis undergoing general anesthesia: A systematic review
Objective: The objective of this study was to analyze available evidence on efficacy and safety of sugammadex in reversing neuromuscular blockades in patients with Myasthenia Gravis (MG), thereby providing a comprehensive understanding of its potential benefits and risks in this specific patient pop...
Saved in:
Main Authors: | Alan D. Kaye, Emily A. Villafarra, Erin S. Everett, Erin E. Ware, Sydney A. Mashaw, William D. Brouillette, Camille G. Elder, Taylor Moss, Luke Muiznieks, Edwin Herron, Shahab Ahmadzadeh, Sahar Shekoohi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025001379 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the Effects of Sugammadex Recommended Dose (2 mg/kg) and Fixed Dose of 200 mg on the Reversal of Moderate Neuromuscular Block and Recovery Profile in Adult Patients
by: Ji-Yoon Jung, et al.
Published: (2025-01-01) -
Distal muscle weakness as the main onset symptom in thymoma-associated myasthenia gravis: a case report and literature review
by: Xuan Wu, et al.
Published: (2025-01-01) -
Effect of Different Doses of Sugammadex on Recovery and Hemodynamic Parameters in Reversing Neuromuscular Blockade in Patients Undergoing Electroconvulsive Therapy
by: Kadir ARSLAN, et al.
Published: (2024-03-01) -
Multiple Brain Abscesses in a Patient with Myasthenia Gravis – a Case Report
by: S. Radzevičiūtė, et al.
Published: (2023-12-01) -
The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk
by: Mohamed Khateb, et al.
Published: (2025-01-01)